Sage Journals: Discover world-class research

Abstract

Objective

Early reports of less invasive techniques for left ventricular assist device (LVAD) implantation have demonstrated promising results. We sought to investigate the safety and feasibility of implementing the complete sternal-sparing (CSS) approach for LVAD implantation in patients with a history of prior cardiac operation.

Methods

This was a retrospective review of prospectively collected data for all patients implanted with a fully magnetically levitated LVAD from April 2017 through December 2018. Patients were dichotomized based on surgical approach: CSS or full median sternotomy (FS). Perioperative complications and overall survival were compared between cohorts.

Results

Of the 29 eligible patients, 15 (52%) were implanted via the CSS approach and 14 (48%) via FS. Preoperative characteristics were similar between cohorts. Overall survival to discharge was 93% for CSS compared to 71% for FS (P = 0.169). The CSS cohort demonstrated fewer postoperative complications, including fewer cases of severe right ventricular failure (P = 0.006) and less blood product utilization (P = 0.015). Median hospital length of stay was significantly shorter for the CSS cohort (median 13 vs 32.5 days, P = 0.016). Neither cohort had any 30-day readmissions.

Conclusions

Early data suggest that the CSS technique is a safe and effective technique for patients with a history of prior sternotomy. Further studies are needed to validate this single-center experience.

Keywords

ventricular assist devices minimally invasive surgery operative surgical procedure adult cardiac

Get full access to this article

View all access options for this article.

References

Rose

EA.

Gelijns

AC.

Moskowitz

et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435–1443.doi:10.1056/NEJMoa012175

Mehra

MR.

Uriel

Naka

et al. A fully magnetically levitated left ventricular assist device - final report. N Engl J Med 2019; 380: 1618–1627.doi:10.1056/NEJMoa1900486

Rogers

JG.

Pagani

FD.

Tatooles

et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med 2017; 376: 451–460.doi:10.1056/NEJMoa1602954

Milano

CA.

Rogers

JG.

Tatooles

et al. HVAD: The ENDURANCE Supplemental Trial. JACC Heart Fail 2018; 6: 792–802.doi:10.1016/j.jchf.2018.05.012

Kormos

RL.

Cowger

Pagani

et al. The Society of Thoracic Surgeons Intermacs Database Annual Report: evolving indications, outcomes, and scientific partnerships. Ann Thorac Surg 2019; 107: 341–353.doi:10.1016/j.athoracsur.2018.11.011

Kirklin

JK.

Pagani

FD.

Kormos

et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 2017; 36: 1080–1086.doi:10.1016/j.healun.2017.07.005

Carrozzini

Bejko

Guariento

et al. Minimally invasive implantation of continuous flow left ventricular assist devices: the evolution of surgical techniques in a single-center experience. Artif Organs 2019; 43: E41–E52.doi:10.1111/aor.13339

McGee

Danter

Strueber

et al. Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: the LATERAL clinical trial. J Heart Lung Transplant 2019; 38: 344–351.doi:10.1016/j.healun.2019.02.002

Wood

KL.

Ayers

Sagebin

et al. Complete sternal-sparing HeartMate 3 implantation: a case series of 10 consecutive patients. Ann Thorac Surg 2019; 107: 1160–1165.doi:10.1016/j.athoracsur.2018.10.005

10.

Maltais

Anwer

LA.

Tchantchaleishvili

et al. Left lateral thoracotomy for centrifugal continuous-flow left ventricular assist device placement: an analysis from the Mechanical Circulatory Support Research Network. ASAIO J 2018; 64: 715–720.doi:10.1097/MAT.0000000000000714

11.

Kocabeyoglu

SS.

Kervan

Sert

et al. Is it possible to implant HeartMate 3 less invasively? New pump, new approach. Artif Organs 2018; 42: 1132–1138.doi:10.1111/aor.13289

12.

Krabatsch

Drews

Potapov

et al. Different surgical strategies for implantation of continuous-flow VADs-Experience from Deutsches Herzzentrum Berlin. Ann Cardiothorac Surg 2014; 3: 472–474.doi:10.3978/j.issn.2225-319X.2014.09.06

13.

Wert

Chatterjee

Dogan

et al. Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock. J Thorac Dis 2018; 10(Suppl 15): S1696–S1702.doi:10.21037/jtd.2018.01.27

14.

Mohite

PN.

Sabashnikov

Raj

et al. Minimally invasive left ventricular assist device implantation: a comparative study. Artif Organs 2018; 42: 1125–1131.doi:10.1111/aor.13269

15.

Burger

Straube

Behne

et al. Role of pericardial constraint for right ventricular function in humans. Chest 1995; 107: 46–49.doi:10.1378/chest.107.1.46

16.

Ayers

Stahl

Wood

et al. Regional nerve block decreases opioid use after complete sternal-sparing left ventricular assist device implantation. J Card Surg 2019; 34: 250–255.doi:10.1111/jocs.14008

Complete Sternal-Sparing Approach Improves Outcomes for Left Ventricular Assist Device Implantation in Patients With History of Prior Sternotomy

Abstract

Objective

Methods

Results

Conclusions

Keywords

Get full access to this article

References